Cargando…

CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer

BACKGROUND: The objectives of this retrospective study were to evaluate the usefulness of computed tomography lymphography (CTL) and to clarify the optimal timing of CTL in sentinel lymph node (SLN) mapping of clinically N0 early oral cancer. METHODS: Twenty patients with clinically N0 early oral ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Satomi, Iwai, Toshinori, Izumi, Toshiharu, Ishiguro, Keita, Baba, Junichi, Oguri, Senri, Mitsudo, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852886/
https://www.ncbi.nlm.nih.gov/pubmed/31718717
http://dx.doi.org/10.1186/s40644-019-0258-9
_version_ 1783469938071044096
author Sugiyama, Satomi
Iwai, Toshinori
Izumi, Toshiharu
Ishiguro, Keita
Baba, Junichi
Oguri, Senri
Mitsudo, Kenji
author_facet Sugiyama, Satomi
Iwai, Toshinori
Izumi, Toshiharu
Ishiguro, Keita
Baba, Junichi
Oguri, Senri
Mitsudo, Kenji
author_sort Sugiyama, Satomi
collection PubMed
description BACKGROUND: The objectives of this retrospective study were to evaluate the usefulness of computed tomography lymphography (CTL) and to clarify the optimal timing of CTL in sentinel lymph node (SLN) mapping of clinically N0 early oral cancer. METHODS: Twenty patients with clinically N0 early oral cancer underwent CTL with a 128 multi-detector row CT scanner to detect SLN the day before resection of primary tumor and SLN biopsy with indocyanine green (ICG) fluorescence guidance. CT scanning was performed in the first 10 patients at 2, 5, and 10 min after submucosal injection of iopamidol and in the remaining 10 patients at 2, 3.5, 5, and 10 min after the injection of contrast medium. We evaluated the SLN detection rate at each scan timing and the number and location of SLNs. We evaluated whether CTL-enhanced SLNs could be identified intraoperatively as ICG fluorescent lymph nodes. RESULTS: SLNs were detected by CTL in 19 of the 20 patients (95.0%), and the mean number of SLNs was 2 (range, 1–4). All SLNs were located on the ipsilateral side; 35 of 37 SLNs were located at level I and II, and 2 SLNs were lingual lymph nodes. All SLNs could be detected 2 min and 3.5–5 min after contrast medium injection, and CTL-enhanced SLNs could be identified intraoperatively as fluorescent lymph nodes. CONCLUSIONS: CTL could facilitate the detection of SLNs in early oral cancer, and the optimal timing of CT scanning was at 2 and 5 min after injection of contrast medium.
format Online
Article
Text
id pubmed-6852886
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68528862019-11-20 CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer Sugiyama, Satomi Iwai, Toshinori Izumi, Toshiharu Ishiguro, Keita Baba, Junichi Oguri, Senri Mitsudo, Kenji Cancer Imaging Research Article BACKGROUND: The objectives of this retrospective study were to evaluate the usefulness of computed tomography lymphography (CTL) and to clarify the optimal timing of CTL in sentinel lymph node (SLN) mapping of clinically N0 early oral cancer. METHODS: Twenty patients with clinically N0 early oral cancer underwent CTL with a 128 multi-detector row CT scanner to detect SLN the day before resection of primary tumor and SLN biopsy with indocyanine green (ICG) fluorescence guidance. CT scanning was performed in the first 10 patients at 2, 5, and 10 min after submucosal injection of iopamidol and in the remaining 10 patients at 2, 3.5, 5, and 10 min after the injection of contrast medium. We evaluated the SLN detection rate at each scan timing and the number and location of SLNs. We evaluated whether CTL-enhanced SLNs could be identified intraoperatively as ICG fluorescent lymph nodes. RESULTS: SLNs were detected by CTL in 19 of the 20 patients (95.0%), and the mean number of SLNs was 2 (range, 1–4). All SLNs were located on the ipsilateral side; 35 of 37 SLNs were located at level I and II, and 2 SLNs were lingual lymph nodes. All SLNs could be detected 2 min and 3.5–5 min after contrast medium injection, and CTL-enhanced SLNs could be identified intraoperatively as fluorescent lymph nodes. CONCLUSIONS: CTL could facilitate the detection of SLNs in early oral cancer, and the optimal timing of CT scanning was at 2 and 5 min after injection of contrast medium. BioMed Central 2019-11-12 /pmc/articles/PMC6852886/ /pubmed/31718717 http://dx.doi.org/10.1186/s40644-019-0258-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sugiyama, Satomi
Iwai, Toshinori
Izumi, Toshiharu
Ishiguro, Keita
Baba, Junichi
Oguri, Senri
Mitsudo, Kenji
CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer
title CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer
title_full CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer
title_fullStr CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer
title_full_unstemmed CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer
title_short CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer
title_sort ct lymphography for sentinel lymph node mapping of clinically n0 early oral cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852886/
https://www.ncbi.nlm.nih.gov/pubmed/31718717
http://dx.doi.org/10.1186/s40644-019-0258-9
work_keys_str_mv AT sugiyamasatomi ctlymphographyforsentinellymphnodemappingofclinicallyn0earlyoralcancer
AT iwaitoshinori ctlymphographyforsentinellymphnodemappingofclinicallyn0earlyoralcancer
AT izumitoshiharu ctlymphographyforsentinellymphnodemappingofclinicallyn0earlyoralcancer
AT ishigurokeita ctlymphographyforsentinellymphnodemappingofclinicallyn0earlyoralcancer
AT babajunichi ctlymphographyforsentinellymphnodemappingofclinicallyn0earlyoralcancer
AT ogurisenri ctlymphographyforsentinellymphnodemappingofclinicallyn0earlyoralcancer
AT mitsudokenji ctlymphographyforsentinellymphnodemappingofclinicallyn0earlyoralcancer